BCWM LLC’s Biogen BIIB Stock Holding History

BCWM LLC’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-782	Closed	-$227K	–	68
2018 Q2	$227K	Hold	782	–	–	0.1%	70
2018 Q1	$214K	Hold	782	–	–	0.09%	65
2017 Q4	$249K	Hold	782	–	–	0.1%	65
2017 Q3	$245K	Hold	782	–	–	0.1%	66
2017 Q2	$212K	Hold	782	–	–	0.09%	68
2017 Q1	$214K	Sell	782 -73	-9%	-$20.6K	0.1%	69
2016 Q4	$243K	Hold	855	–	–	0.11%	67
2016 Q3	$268K	Sell	855 -55	-6%	-$16.3K	0.12%	66
2016 Q2	$220K	Hold	910	–	–	0.11%	66
2016 Q1	$237K	Buy	910 +5	+0.6%	+$1.32K	0.13%	72
2015 Q4	$278K	Buy	+905	New	+$260K	0.17%	73
2015 Q3	–	Sell	-684	Closed	-$277K	–	97
2015 Q2	$277K	Sell	684 -121	-15%	-$48.6K	0.12%	90
2015 Q1	$340K	Hold	805	–	–	0.16%	74
2014 Q4	$273K	Sell	805 -58	-7%	-$18.8K	0.13%	83
2014 Q3	$286K	Sell	863 -60	-7%	-$19.8K	0.14%	85
2014 Q2	$292K	Hold	923	–	–	0.15%	82
2014 Q1	$282K	Sell	923 -100	-10%	-$31.7K	0.15%	77
2013 Q4	$286K	Sell	1,023 -148	-13%	-$38.3K	0.16%	73
2013 Q3	$282K	Hold	1,171	–	–	0.17%	69
2013 Q2	$252K	Buy	+1,171	New	+$250K	0.15%	73

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BCWM LLC's BIIB Position: Q3 2018 in Review

BCWM LLC sold out of Biogen (BIIB) in Q3 2018, closing a stake of 782 shares — an estimated $227K sold.

BCWM LLC first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $340K in Q1 2015. 1,146 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

BCWM LLC reported no remaining Biogen position as of Q3 2018 after selling out during the quarter.
BCWM LLC sold 782 Biogen shares in Q3 2018, an estimated $227K.
BCWM LLC first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
BCWM LLC's Biogen position peaked at $340K in Q1 2015.
1,146 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on BCWM LLC's 13F filing for Q3 2018, filed 14 Nov 2018.